-+ 0.00%
-+ 0.00%
-+ 0.00%

City Therapeutics Director Robert Nelsen Reports $3.06 Million Common Share Acquisition

PUBT·10/19/2026 21:40:06
City Therapeutics Director Robert Nelsen Reports $3.06 Million Common Share Acquisition
  • City Therapeutics director and 10% owner Robert Nelsen reported an indirect purchase of 170,000 common shares at $18 each.
  • His reported indirect holdings totaled 13,692,507 common shares through ARCH Venture Fund XII.
  • Conversions of Series Seed, Series A and Series B convertible preferred stock added 10,804,215 common shares.
  • Nelsen also received options to buy 22,649 common shares at an $18 exercise price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. City Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-116965), on October 19, 2026, and is solely responsible for the information contained therein.